BLSM

BlossomHill Therapeutics, Inc.

Healthcare · Biotechnology

19.90$ +1.3% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BLSM
Line item	Q1 25	Q2 25	Q1 26	Q2 26
Revenue	0.00	–	0.00	0.00
Research & Development	0.33	–	0.68	0.79
Selling, General & Administrative	0.06	–	0.08	0.12
Total Operating Expenses	0.39	–	0.76	0.91
Operating Income	-0.39	–	-0.76	-0.91
Pre-Tax Income	-0.36	–	-0.72	-0.88
Net Income	-0.36	–	-0.72	-0.88
EBITDA	-0.39	–	-0.76	-0.91

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.